Research & Innovation at the Bass Center

Since childhood cancers are so rare, most young patients are referred here because of our expertise and experience. At Lucile Packard Children's Hospital Stanford, our pediatric cancer treatment and research program is known globally for the treatment of non-Hodgkin's lymphoma, Hodgkin's disease, leukemia and brain tumors.

As a part of the NCI-designated Stanford Cancer Institute, the Bass Center works with some of the brightest and most innovative physician-scientists. In addition, our physicians hold leadership roles in Children's Oncology Group (COG), a national clinical research consortium. This group — which represents the merger of four national pediatric cancer research groups — designs and evaluates cancer therapies through large clinical trials. We also conduct a number of trials of experimental drugs that can offer new treatment options for patients who have failed other therapies.

To find out more about our current trials, see our list of clinical trials or call (650) 497-8953.

Pioneering immunotherapy to find and kill cancer cells

Our physicians and researchers are working at the forefront of cancer immunotherapy, a promising field of cancer treatment. One type of immunotherapy, CAR-T cell therapy, uses a patient’s own genetically modified immune cells to track down and attack leukemia cells. Learn more about one patient’s journey with this groundbreaking therapy.

Genome sequencing for childhood cancers

Lucile Packard Children’s Hospital Stanford has assembled a team of world-class clinicians, cancer biologists, computer scientists and clinical genetics experts who are utilizing high-throughput sequencing to improve the care of pediatric patients with cancer. Learn more about our unique approach.

Stanford Cancer Institute logo